Skip to content

Clinical trials

Dementia trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dementia Country / region: Japan Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20072
20114
20123
20142
20153
20162
20171
20182
20201
20214
20221
20231
20243
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Terminated8
Active, not recruiting5
Recruiting5
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eisai Co., Ltd.6
Eli Lilly and Company6
AstraZeneca3
Bristol-Myers Squibb3
Janssen Pharmaceutical K.K.2
Janssen Research & Development, LLC2
Tanabe Pharma Corporation2
Washington University School of Medicine2
AbbVie1
Eisai Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dementia34
Alzheimer Disease27
Cognitive Dysfunction12
Tauopathies8
Brain Diseases7
Central Nervous System Diseases6
Mental Disorders6
Nervous System Diseases6
Neurodegenerative Diseases6
Lewy Body Disease4

Trials

Showing 51 to 34 of 34. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.